Clinical Trials List
Protocol NumberCC-220-DLBCL-002
NCT Number(ClinicalTrials.gov Identfier)-
2021-08-01 - 2021-09-27
Phase I/II
Terminated2
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Principal Investigator
Tai-Chung Huang
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
252 participants
